Clinical Trials on Gram-Positive Bacterial Infections

Total 8112 results

Pfizer

Completed

SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults

Staphylococcal Infections

Japan
Pfizer

Completed

Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Staphylococcal Infections

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age

Streptococcal Infections

South Africa
Hillel Yaffe Medical Center

Unknown

Preoperative Nasal Swabs From Pediatric Patients

Staphylococcal Infections

Israel
National Taiwan University Hospital

Unknown

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

Staphylococcal Infections

Taiwan
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Clostridium Infections

Belgium
Centre Hospitalier Universitaire de Saint Etienne

Completed

Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery (SREENSTAPH2)

Staphylococcal Infections

France
GlaxoSmithKline

Completed

A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

Streptococcal Infections

Germany
University of Michigan

Withdrawn

Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study

Streptococcal Infections

United States
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease

Clostridium Infections

United States
Sanofi

Completed

Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

Clostridium Infections
Pfizer

Completed

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

Staphylococcal Infections
University of Pittsburgh

Completed

Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes

Clostridium Infections

United States
Nabi Biopharmaceuticals
Public Health England

Completed

StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery

Staphylococcal Infections

United Kingdom
Hospices Civils de Lyon
Exeliom Biosciences

Recruiting

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (LIVEDIFF)

Clostridioides Difficile Infection | Recurrent Infection

France
University of Pittsburgh
Merck Sharp & Dohme LLC

Withdrawn

Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)

Clostridium Difficile Infection (CDI)

United States
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Enrolling by invitation

FQ Restriction for the Prevention of CDI (FIRST)

Clostridium Difficile Infection | Clostridium Difficile | C Difficile Colitis

United States
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Completed

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation (GRAFT)

Clostridium Difficile Infection | CDI | C.Difficile Diarrhea

United States
Roma Tre University
Merck Sharp & Dohme LLC

Unknown

Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection

Clostridium Difficile Infection | Clostridium Difficile
Andrej Trampuz
University of Lausanne Hospitals; Schulthess Klinik; Kantonsspital Liestal

Unknown

Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection (Dapto-Studie)

Staphylococcal Infections

Switzerland
Sinovac Research and Development Co., Ltd.

Recruiting

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease

China
Walvax Biotechnology Co., Ltd.
Air Force Military Medical University, China; Guangxi Center for Disease Control...

Completed

Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children

Pneumococcal Infectious Diseases

China
Rochester General Hospital

Terminated

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

Clostridium Difficile Infection

United States
Ferring Pharmaceuticals

Recruiting

REBYOTA™ Prospective Registry (ROAR)

Recurrence of Clostridium Difficile Infection

United States
Hospices Civils de Lyon

Recruiting

Recurrent S. Aureus Infections in Osteoarticular Infections (RELAPSTAPH)

Staphylococcus Aureus Infection | Bone and Joint Infection

France
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens.

Gram-Negative Bacterial Infections | Gram-Positive Bacterial Infections | Meningitis | Neurosurgery | Ventriculitis | Intracranial Infections
Thomas Benfield

Recruiting

Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV (MENPI)

Pneumococcal Infections | Hiv | Meningococcal Infections

Denmark
MassBiologics
Medarex

Completed

Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease

Clostridium Infections

United States, Canada
Pfizer

Completed

Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years

Staphylococcal Infections

United States
University of Cologne

Unknown

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation (MicroTrans)

Clostridium Infections

Germany
Centre Hospitalier Universitaire de Saint Etienne

Completed

Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne (ScreenStaph)

Staphylococcal Infections

France
Merck Sharp & Dohme LLC

Completed

V710 First-In-Man (FIM) Study (V710-001)

Staphylococcal Infections
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)

Staphylococcal Infections
Nabi Biopharmaceuticals
Vanderbilt University

Completed

Evaluation of Consistency of StaphVAX Manufacturing Lots

Staphylococcal Infections

United States
Sanofi

Completed

Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers

Clostridium Infections

United States
University of Sao Paulo

Unknown

Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant

Staphylococcal Infections

Brazil
Synthetic Biologics Inc.

Completed

A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Clostridium Infections | Clostridium Difficile

United States, Bulgaria, Canada, Hungary, Poland, Romania, Serbia
Christiana Care Health Services
Sage Products, Inc.

Completed

Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections

Staphylococcal Infections

United States
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase II Study of Range and Schedule of rPA Doses

Prevention of Bacillus Anthracis (Anthrax) Infection

United Kingdom
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Not yet recruiting

Virus as Treatment of C. Difficile Infection (VISION) (VISION)

Clostridium Difficile Infections

Denmark
University Hospital, Rouen

Unknown

Burden of Staphylococcus Lugdunensis Infections in Hospitalized Patients (INHOSTAL)

Staphylococcus Lugdunensis Infection

France
GlaxoSmithKline

Completed

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

Infections, Clostridium Difficile

United States, Canada
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Molecular Epidemiology of Clostridium Difficile Infections in Children

Clostridium Difficile Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age

Meningitis | Meningococcal Infection

United States
Fondation Hôpital Saint-Joseph

Recruiting

Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance (DECLIC)

Clostridium Difficile Infections

France
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to Mycobacterium Tuberculosis Infection

Latent Tuberculosis

United States, Mali
National Taiwan University Hospital

Unknown

Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis Population

Patients on Dialysis

Taiwan
Shanghai Public Health Clinical Center

Unknown

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

AIDS

China
Taichung Veterans General Hospital
Centers for Disease Control and Prevention; ChungHwa Veterans house; Taiwan Province...

Unknown

Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers

Latent Tuberculosis | Tuberculosis | Elderly | Tuberculosis Contact

China
Central Hospital, Nancy, France

Completed

Antistaphylococcal Betalactam and Emergence of Resistance (CePasR)

Bacterial Resistance | Methicillin-Sensitive Staphylococcus Aureus Infection

France

Clinical Trials on Gram-Positive Bacterial Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations